1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ibuprofen in 16 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (ibuprofen) | Trials (ibuprofen) | Recent Studies (post-2010) (ibuprofen) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 10,245 | 1,781 | 4,267 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | ibuprofen (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 2.9 | |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | 1.1 | |
| Albumin | Bos taurus (cattle) | 3 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 4.0919 | |
| Prostaglandin G/H synthase 1 | Mus musculus (house mouse) | 0.22 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 1.6273 | |
| Caspase-1 | Homo sapiens (human) | 7.2667 | |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | 1.1 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3.0687 | |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 1.3 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 10 | |
| Caspase-3 | Homo sapiens (human) | 7.2667 | |
| Caspase-4 | Homo sapiens (human) | 7.2667 | |
| 4-aminobutyrate aminotransferase, mitochondrial | Rattus norvegicus (Norway rat) | 1.1 | |
| Caspase-5 | Homo sapiens (human) | 7.2667 | |
| Caspase-9 | Homo sapiens (human) | 7.2667 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 1.1375 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 2.9 | |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 5 | |
| Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 0.54 | |
| Solute carrier family 22 member 6 | Homo sapiens (human) | 8 | |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 1.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 13 (81.25) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, K; Mochizuki, K; Ohta, M; Shiota, M; Sugano, T | 1 |
| DeBuysere, MS; Gandhi, CR; Olson, MS | 1 |
| Bautista, AP; Spitzer, JJ | 1 |
| Grunfeld, S; Han, E; Joseph, R; Welch, KM | 1 |
| Kaliner, M; Logun, C; Lundgren, JD; Shelhamer, JH | 1 |
| Baum, TD; Feldman, HS; Fink, MP; Heard, SO; Latka, CA | 1 |
| Adi, S; Feingold, KR; Fiers, W; Grunfeld, C; Moser, A; Soued, M | 1 |
| Lapointe, DS; Olson, MS | 1 |
| Makowka, L; Mazzaferro, V; Ontell, SJ; Ove, P; Starzl, TE; Trager, J | 1 |
| Fletcher, JR; Khimenko, PL; Logsdon, P; Rizzo, A; Taylor, AE; Townsley, MI | 1 |
| Rola-Pleszczynski, M; Thivierge, M | 1 |
| Iwao, H; Kim, S; Miura, K; Yamanaka, S; Yukimura, T | 1 |
| Kroegel, C; Matthys, H | 1 |
| Mue, S; Ohuchi, K; Watanabe, M; Yamada, M | 1 |
| Ebara, T; Imanishi, M; Iwao, H; Kim, S; Matsuura, T; Miura, K; Yamano, Y | 1 |
| Downing, SJ; Leese, HJ; Maguiness, SD; Tay, JI; Watson, A | 1 |
16 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ibuprofen
| Article | Year |
|---|---|
Different preparations of zymosan induce glycogenolysis independently in the perfused rat liver. Involvement of mannose receptors, peptide-leukotrienes and prostaglandins.
Topics: Animals; Chromones; Glycogen; Hot Temperature; Ibuprofen; Isoproterenol; Liver; Male; Mannans; Masoprocol; Opsonin Proteins; Platelet Activating Factor; Prostaglandins; Rats; Rats, Inbred Strains; Receptors, Immunologic; Receptors, Leukotriene; Solubility; Zymosan | 1992 |
Platelet-activating factor-mediated synthesis of prostaglandins in rat Kupffer cells.
Topics: Animals; Bacterial Toxins; Calcium; Cells, Cultured; Cyclic AMP; Enzyme Activation; Ibuprofen; Kupffer Cells; Male; Masoprocol; Platelet Activating Factor; Prostaglandins; Protein Kinase C; Rats; Rats, Inbred Strains | 1992 |
Platelet activating factor stimulates and primes the liver, Kupffer cells and neutrophils to release superoxide anion.
Topics: Animals; Anions; Free Radicals; Ibuprofen; In Vitro Techniques; Kupffer Cells; Lipopolysaccharides; Liver; Male; Neutrophils; Peroxidase; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxides; Zymosan | 1992 |
[Effect of chronic antiplatelet treatment on platelet activating factor-induced platelet activity in stroke].
Topics: Adenosine Triphosphate; Adult; Aspirin; Calcium; Cerebrovascular Disorders; Female; Humans; Ibuprofen; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation | 1991 |
Platelet activating factor and tracheobronchial respiratory glycoconjugate release in feline and human explants: involvement of the lipoxygenase pathway.
Topics: Animals; Bronchi; Cats; Culture Techniques; Glyceryl Ethers; Glycoconjugates; Humans; Ibuprofen; Lipoxygenase; Masoprocol; Platelet Activating Factor; Thiazoles; Trachea; Tritium | 1990 |
Endotoxin-induced myocardial depression in rats: effect of ibuprofen and SDZ 64-688, a platelet activating factor receptor antagonist.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Body Weight; Depression, Chemical; Endotoxins; Escherichia coli; Heart Rate; Ibuprofen; In Vitro Techniques; Lipopolysaccharides; Male; Myocardial Contraction; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1990 |
Search for mediators of the lipogenic effects of tumor necrosis factor: potential role for interleukin 6.
Topics: Animals; Aspirin; Azepines; Cholesterol; Fatty Acids; Ibuprofen; Interleukin-6; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Oleic Acid; Oleic Acids; Pentoxifylline; Phenoxybenzamine; Platelet Activating Factor; Propranolol; Rats; Rats, Inbred Strains; Reference Values; Triazoles; Triglycerides; Tumor Necrosis Factor-alpha | 1990 |
Platelet-activating factor-stimulated hepatic glycogenolysis is not mediated through cyclooxygenase-derived metabolites of arachidonic acid.
Topics: Animals; Arachidonic Acids; Glucose; Ibuprofen; Liver; Liver Circulation; Liver Glycogen; Male; Platelet Activating Factor; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Strains; Reference Values; Thromboxane B2; Vascular Resistance | 1989 |
Pharmacologic modulation of experimental postischemic hepatic function.
Topics: Animals; Bile; Disease Models, Animal; Drug Evaluation, Preclinical; Hot Temperature; Ibuprofen; Ischemia; Liver; Male; Microscopy, Electron; Perfusion; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred Strains; Reperfusion Injury; Superoxide Dismutase; Transaminases | 1989 |
Platelet-activating factor increases vascular resistance in rat hindquarters by thromboxane A2.
Topics: Animals; Azepines; Blood Pressure; Capillary Permeability; Hindlimb; Ibuprofen; Male; Phenylacetates; Platelet Activating Factor; Rats; Rats, Wistar; Regional Blood Flow; Sulfonamides; Thromboxane A2; Thromboxanes; Triazoles; Vascular Resistance | 1995 |
Involvement of both cyclooxygenase and lipoxygenase pathways in platelet-activating factor-induced interleukin-6 production by alveolar macrophages.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Arachidonate 5-Lipoxygenase; Aspirin; Bucladesine; Cyclooxygenase Inhibitors; Dinoprostone; Ibuprofen; Indomethacin; Interleukin-6; Leukotriene B4; Macrophages, Alveolar; Male; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 1994 |
Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock.
Topics: Animals; Dogs; Endotoxins; Female; Hemodynamics; Ibuprofen; Isoquinolines; Male; Nitric Oxide; Platelet Activating Factor; Pyridinium Compounds; Shock, Septic; Tetrahydroisoquinolines | 1993 |
Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics.
Topics: Asthma; Cells, Cultured; Dose-Response Relationship, Drug; Eosinophils; Humans; Ibuprofen; Leukocytes; Platelet Activating Factor; Prostaglandins; Thromboxane B2 | 1993 |
Enhancement by cyclo-oxygenase inhibitors of platelet-activating factor production in thapsigargin-stimulated macrophages.
Topics: Animals; Arachidonic Acid; Bucladesine; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Ibuprofen; Indomethacin; Macrophages, Peritoneal; Male; Naproxen; Platelet Activating Factor; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Terpenes; Thapsigargin | 1995 |
Role of platelet-activating factor and prostanoids in hemodynamic changes in rat experimental endotoxic shock.
Topics: Animals; Bridged Bicyclo Compounds; Fatty Acids, Monounsaturated; Hemodynamics; Ibuprofen; Isoquinolines; Male; Platelet Activating Factor; Prostaglandins; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Shock, Septic; Tetrahydroisoquinolines | 1996 |
Effect of inflammatory mediators on the physiology of the human Fallopian tube.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cells, Cultured; Diclofenac; Dose-Response Relationship, Drug; Electric Conductivity; Electrophysiology; Epithelial Cells; Fallopian Tubes; Female; Histamine; Humans; Ibuprofen; Indomethacin; Inflammation Mediators; Muscle Contraction; Muscle, Smooth; Naproxen; Pelvic Pain; Platelet Activating Factor | 2002 |